Meclizine: Mechanism of Action, Indications and Important Notes
Meclizine is a first-generation antihistamine used for dizziness, nausea and vomiting. The active substance shows particular properties in complaints related to the vestibular system and balance. Meclizine is used in various countries both for the treatment of motion sickness and for vestibularly caused dizziness. In some countries, meclizine is also available without a prescription; in Germany, the situation with regard to availability and authorisation is shaped by other comparable active substances.
Dizziness is one of the most common complaints in general medicine and neurological practice. The causes are varied and range from benign paroxysmal positional vertigo to Menière's disease, vestibular neuritis and central nervous system disorders. Treatment choice is guided by the underlying cause, while symptomatic measures such as meclizine can be used for certain forms of acute vestibular dizziness.
Mechanism of Action
Meclizine acts as an antagonist at H1 histamine receptors and additionally shows anticholinergic properties through blockade of muscarinic receptors. This combination is essential for the antiemetic and antivertiginous effect.
Antihistaminic Effect
By blocking central H1 receptors, meclizine dampens the processing of vestibular signals in the brain. The vestibular system is closely connected to the vomiting centre in the brainstem. Inhibition of H1 receptors in these brain regions reduces the hypersensitivity of the vomiting centre to stimuli originating from the inner ear. This explains why antihistamines with central targeting can be effective in vestibular dizziness and motion sickness.
Anticholinergic Effect
The anticholinergic component of meclizine also contributes to the antiemetic effect. Muscarinic receptors in the gastrointestinal tract and central nervous system are involved in triggering nausea and vomiting. Their blockade by meclizine reduces sensitivity to emetic stimuli from the vestibular system. The anticholinergic effect is also responsible for some of meclizine's side effects, such as dry mouth and blurred vision.
Central Sedation
As a first-generation antihistamine, meclizine crosses the blood-brain barrier and exerts a sedating effect. This sedation is partly therapeutically desired in the treatment of dizziness and vomiting, as it also dampens the perception of unpleasant bodily signals. At the same time, sedation restricts everyday abilities and the ability to drive.
Indications
Motion Sickness (Kinetosis)
Meclizine is used preventively and therapeutically for motion sickness. Kinetosis arises from conflicts between the information that the vestibular system (vestibular organ), the eyes and other sensory organs send to the brain. Particularly on sea voyages, long car journeys and air travel, this can lead to nausea, vomiting and a feeling of dizziness. Meclizine can be taken before travel to alleviate or prevent these complaints.
Vestibular Dizziness
In acute vestibular dizziness, for example in vestibular neuritis or acute exacerbation of Menière's disease, meclizine can be used for symptomatic relief. In Menière's disease, characterised by episodic attacks of rotational dizziness, tinnitus and hearing loss, meclizine can dampen vestibular symptoms in the acute phase. Causal treatment of the underlying condition is not replaced by this.
Postoperative and Drug-Induced Dizziness
In certain clinical situations where dizziness and nausea are triggered by other influences, meclizine can be used as part of a symptomatic treatment concept. This must always be decided by a physician.
Dosage Forms and Dosing
Meclizine is available as tablets for oral administration in some countries. Dosing depends on the indication and individual response. For prophylaxis of motion sickness, meclizine is taken approximately one hour before the start of travel. Exact dosing information is provided in the package leaflet and should be coordinated with the treating physician. In Germany, the data on the availability of meclizine as an approved preparation is specific; medical advice on available alternatives is recommended.
Important Notes
Meclizine can significantly impair the ability to drive and operate machinery. The sedating effect may vary depending on individual sensitivity. Driving vehicles should be avoided during use, or approached very carefully after medical consultation. Alcohol enhances the sedating effect of meclizine and should therefore be avoided during use.
Meclizine should only be used after medical consultation in patients with angle-closure glaucoma, urinary retention, bladder emptying disorders, severe liver disease or certain cardiac arrhythmias. Older patients are particularly sensitive to anticholinergic side effects.
Adverse Effects
The side effects of meclizine are associated with its antihistaminic and anticholinergic action:
- Drowsiness and sedation, common
- Dry mouth
- Blurred vision due to accommodation disorders
- Urinary retention (particularly in older men with prostatic enlargement)
- Constipation
- Headache
- Palpitations in rare cases
- In older patients: increased risk of falls and confusion due to sedating and anticholinergic effects
Drug Interactions
The sedating effect of meclizine is enhanced by simultaneous use of other centrally depressant substances. These include other antihistamines, benzodiazepines, sleeping medications, opioids and alcohol. The anticholinergic effect is additive when combined with other anticholinergic agents, which increases the risk of anticholinergic complications. The treating physician should always be informed about all medications being taken.
Use in Special Patient Groups
In older patients, first-generation antihistamines such as meclizine should be used with particular caution due to their anticholinergic profile. Anticholinergic substances can predispose older people to cognitive impairment, falls and urinary retention. In the Beers List, which identifies potentially inappropriate medications for older patients, first-generation antihistamines are classified as potentially inadequate for older people.
During pregnancy, meclizine should only be used after careful medical assessment. Although animal study data show no evidence of teratogenicity, limited data from studies in humans are available. During breastfeeding, meclizine should be avoided, as antihistamines pass into breast milk and can cause sedation in infants.
Meclizine on Sanoliste
On Sanoliste you will find general practitioners, neurologists, ENT physicians and specialists for dizziness and vestibular disorders. Medical clarification of the cause of dizziness is important, as various conditions require different therapeutic approaches. Not every form of dizziness responds to antihistamines, and in certain forms such as benign paroxysmal positional vertigo, specific manoeuvres are more effective than medications.
The information on this page is for general information purposes only and does not replace advice from a physician.
Frequently Asked Questions about Meclizine
How does meclizine work in motion sickness?
In motion sickness, the vestibular organ in the inner ear registers movements that the eyes do not perceive, or vice versa. This sensory conflict leads to activation of the vomiting centre in the brainstem, which is closely networked with the vestibular system. Meclizine blocks H1 receptors in these brain structures and thus dampens hypersensitivity to vestibular signals. The anticholinergic component additionally reduces sensitivity to emetic stimuli. Intake before travel is more effective than intake after symptoms have begun.
Can meclizine be used on a long-term basis in Menière's disease?
In Menière's disease, antivertiginous agents such as meclizine are primarily used to abort acute dizzy attacks. Long-term therapy with antihistamines is generally not recommended in Menière's disease, as long-term anticholinergic effects and sedation can impair quality of life. For attack prophylaxis in Menière's disease, other therapeutic approaches such as betahistine are used. Treatment planning is carried out individually by the ENT physician or neurologist.
What alternatives to meclizine are available for motion sickness?
Various active substances are available for motion sickness, including dimenhydrinate, scopolamine as a transdermal patch and ginger as an herbal option with limited evidence. Dimenhydrinate is a frequently used antiemetic in Germany for motion sickness. Scopolamine acts via anticholinergic mechanisms and is very effective in some patients. Which agent is most suitable for a particular patient depends on individual circumstances, comorbidities and the type of travel.